glutathione and triple negative breast cancer Role of in Cancer: From Mechanisms to Therapies Activation of the eIF2α/ATF4 axis
Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



